Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility
Authors:
- Xavier SoléXSXavier Solé
- Pilar HernándezPHPilar Hernández
- Miguel López de HerediaMHMiguel López de Heredia
- Lluís ArmengolLALluís Armengol
- Benjamín Rodríguez-SantiagoBRBenjamín Rodríguez-Santiago
- Laia GómezLGLaia Gómez
- Christopher A MaxwellCMChristopher A Maxwell
- Fernando AguilóFAFernando Aguiló
- Enric CondomECEnric Condom
- Jesús AbrilJAJesús Abril
- Luis Pérez-JuradoLPLuis Pérez-Jurado
- Xavier EstivillXEXavier Estivill
Open Access
- 11 January 2008
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 12
Abstract
Background: Germline genetic variation is associated with the differential expression of many human genes. The phenotypic effects of this type of variation may be important when considering susceptibility to common genetic diseases. Three regions at 8q24 have recently been identified to independently confer risk of prostate cancer. Variation at 8q24 has also recently been associated with risk of breast and colorectal cancer. However, none of the risk variants map at or relatively close to known genes, with c-MYC mapping a few hundred kilobases distally. Results: This study identifies cis-regulators of germline c-MYC expression in immortalized lymphocytes of HapMap individuals. Quantitative analysis of c-MYC expression in normal prostate tissues suggests an association between overexpression and variants in Region 1 of prostate cancer risk. Somatic c-MYC overexpression correlates with prostate cancer progression and more aggressive tumor forms, which was also a pathological variable associated with Region 1. Expression profiling analysis and modeling of transcriptional regulatory networks predicts a functional association between MYC and the prostate tumor suppressor KLF6. Analysis of MYC/Myc-driven cell transformation and tumorigenesis substantiates a model in which MYC overexpression promotes transformation by down-regulating KLF6. In this model, a feedback loop through E-cadherin down-regulation causes further transactivation of c-MYC. Conclusion: This study proposes that variation at putative 8q24 cis-regulator(s) of transcription can significantly alter germline c-MYC expression levels and, thus, contribute to prostate cancer susceptibility by down-regulating the prostate tumor suppressor KLF6 gene.Keywords
This publication has 73 references indexed in Scilit:
- A common genetic risk factor for colorectal and prostate cancerNature Genetics, 2007
- Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24Nature Genetics, 2007
- A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21Nature Genetics, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- Multiple regions within 8q24 independently affect risk for prostate cancerNature Genetics, 2007
- Common genetic variants account for differences in gene expression among ethnic groupsNature Genetics, 2007
- Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in MiceCancer Cell, 2007
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?Journal of Molecular Medicine, 2005
- Reverse engineering of regulatory networks in human B cellsNature Genetics, 2005